EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival

Kajsa Björner, Wei-Na Chen, Venkata Ram Gannavarapu, Fredrik Axling, Miklos Gulyas, Mohammad Abdul Halim, Dominic-Luc Webb, Per M Hellström

Upsala Journal of Medical Sciences · 2024

DOI: 10.48101/ujms.v128.10241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Upsala Journal of Medical Sciences, 2024. Verfasst von Kajsa Björner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Gastroenterology and Hepatology Section, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Colitis-Associated Neoplasms, Inflammatory Bowel Diseases, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease (IBD; mainly ulcerative colitis and Crohn’s disease) is associated with the development of colorectal cancer (CRC) referred to as colitis-associated colorectal cancer (CAC). In inflammatory flares of IBD, the production of luminal nitric oxide (NO) increases due to the increased inducible nitric oxide synthase (iNOS) activity in inflamed tissue. It is believed that iNOS parallels pro-inflammatory interleukin-1β (IL-1β). How these biomarkers relate to CAC pathogenesis or survival is unknown.

Aim

The primary aim of this study was to investigate iNOS and IL-1β immunoreactivity in CAC tumors in comparison with CRC and normal colonic mucosa, and the secondary aim was to determine if immunoreactivity correlates with 5-year survival of CAC.

Methods

Immunohistochemistry was performed on tissue sections as follows: CAC (n = 59); sporadic CRC (sCRC) (n = 12); colonic mucosa >2 cm outside sCRC margin (normal mucosa) (n = 22); paracancerous IBD (pIBD) (n = 12). The expression of iNOS and IL-1β was quantified separately for epithelium and stroma. Data were evaluated using the Mann-Whitney U-test and the log-rank test for 5-year Kaplan-Meier survival curves. Results were compared with online mRNA databases.

Results

Immunoreactivity occurred predominantly in epithelial cells and to lesser extent in stroma. Compared with normal mucosa, immunoreactivity for iNOS (P < 0.01) and IL-1β (P < 0.005) was higher in CAC epithelium. In CAC stroma, iNOS immunoreactivity was lower than normal mucosa (P < 0.001), whereas IL-1β was higher (P < 0.05). Immunoreactivity differences of iNOS or IL-1β among CAC patients failed to correlate with 5-year survival. These findings were supported by online mRNA databases.

Conclusion

Consistent with high NO production in IBD, there is more iNOS in CAC epithelium, albeit not in stroma. This immunoreactivity difference exists for IL-1β in both epithelium and stroma. The intervention of arginine or iNOS activity for CAC chemotherapy is not straightforward.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis-Associated NeoplasmsInflammatory Bowel DiseasesNeoplasmsHumansInterleukin-1betaNitric Oxide Synthase Type IIRNA, Messenger

Stichwörter der Autor:innen

Colorectal cancerInterleukin-1βcolitis-associated colorectal cancerinducible nitric oxide synthaseinflammatory bowel diseasetumor biology

Substanzen

Interleukin-1betaNitric Oxide Synthase Type IIRNA, MessengerNOS2 protein, humanIL1B protein, human

Autor:innen und Institutionen

  • Department of Medical Sciences, Gastroenterology and Hepatology Section, Uppsala University, Uppsala, Sweden.
  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Zitieren

APA

Björner, K., Chen, W. N., Gannavarapu, V. R., Axling, F., Gulyas, M., Halim, M. A., Webb, D. L., & Hellström, P. M. (2024). High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival. Upsala Journal of Medical Sciences. https://doi.org/10.48101/ujms.v128.10241

Vancouver

Björner K, Chen WN, Gannavarapu VR, Axling F, Gulyas M, Halim MA, et al. High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival. Upsala Journal of Medical Sciences. 2024. doi:10.48101/ujms.v128.10241

BibTeX
@article{Bjrner2024,
  author = {Björner, Kajsa and Chen, Wei-Na and Gannavarapu, Venkata Ram and Axling, Fredrik and Gulyas, Miklos and Halim, Mohammad Abdul and Webb, Dominic-Luc and Hellström, Per M},
  title = {High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival},
  journal = {Upsala Journal of Medical Sciences},
  year = {2024},
  doi = {10.48101/ujms.v128.10241}
}
Kostenlos starten →